Century Therapeutics (IPSC) Operating Income (QoQ) (2020 - 2026)

Century Therapeutics (IPSC) Operating Income (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Century Therapeutics 406.30 Mn 271.49 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.69%
Dec 31, 2025 42.83%
Sep 30, 2025 -4.21%
Jun 30, 2025 -146.73%
Mar 31, 2025 298.95%
Dec 31, 2024 -7.17%
Sep 30, 2024 -0.10%
Jun 30, 2024 -11.01%
Mar 31, 2024 28.46%
Dec 31, 2023 -22.84%
Sep 30, 2023 -1.57%
Jun 30, 2023 -9.34%
Mar 31, 2023 3.68%
Dec 31, 2022 -4.94%
Sep 30, 2022 -1.23%
Jun 30, 2022 16.25%
Mar 31, 2022 -33.83%
Dec 31, 2021 -8.31%
Sep 30, 2021 -12.19%
Jun 30, 2021 -27.46%